Schedule 13G ownership disclosure
EYEGATE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 30233M107
Event date: 2017-06-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,500,000
- Percent of class
- 9.2200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-17-002628
- Form type
- SC 13G
- Filer
- KIORA PHARMACEUTICALS INC
- CIK
- CIK 1372514
- Filed
- Jun 14, 2017
- Reporting period
- Jun 09, 2017
- Description
- Schedule 13G beneficial ownership